Canaccord downgraded Thorne HealthTech to Hold from Buy with a price target of $10, up from $7, after L Catterton agreed to acquire all outstanding shares of common stock of Thorne for $10.20 per share in cash.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on THRN:
- Thorne HealthTech (NASDAQ:THRN) Soars on Acquisition News; Company Going Private
- Thorne HealthTech, Inc. Enters into Definitive Agreement to be Acquired by L Catterton for $10.20 Per Share in Cash
- Thorne HealthTech to be acquired by L Catterton for $10.20 per share in cash
- Thorne HealthTech price target raised to $7 from $6 at Canaccord
- Thorne HealthTech raises FY23 adjusted EPS view to 26c-32c from 25c-31c